Results 1 - 10 of 13 for Ibrutinib
  1. Ibrutinib is used to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins ... who have a specific genetic (inherited) risk factor. Ibrutinib is used to treat people with Waldenström's macroglobulinemia ( ...
  2. ... that are abnormally expressed in the cancer cells. Ibrutinib and idelalisib are novel agents licensed for the ... given in combination with bendamustine. Novel oral agents Ibrutinib — Ibrutinib (brand name: Imbruvica) is a drug that ...
  3. Leukemia Trial Results From the National Institutes of Health (National Cancer Institute)  
    ... Coordinating Center for Clinical Trials Leukemia Trial Results Ibrutinib Improves Survival Compared with Ofatumumab in Patients with ... small lymphocytic lymphoma (SLL) who were treated with ibrutinib (Imbruvica®) lived longer without their disease getting worse ...
  4. Mantle Cell Lymphoma (Leukemia & Lymphoma Society)  
    ... for untreated patients in a combination therapy. l Ibrutinib (Imbruvica®), a Bruton tyrosine kinase (BTK) inhibitor, is ... lenalidomide) in June 2013 and the BTK inhibitor ibrutinib (Imbruvica®) in November 2013. Imbruvica is a very ...
  5. Targeted Cancer Therapies From the National Institutes of Health (National Cancer Institute)  
    ... rituximab (Rituxan®) , alemtuzumab (Campath®) , ofatumumab (Arzerra®) , obinutuzumab (Gazyva™) , ibrutinib (Imbruvica™) , idelalisib (Zydelig®) , blinatumomab (Blincyto™) Liver cancer: Sorafenib ( ...
  6. Drugs Approved for Non-Hodgkin Lymphoma From the National Institutes of Health (National Cancer Institute)  
    ... Methotrexate) Folex PFS (Methotrexate) Folotyn (Pralatrexate) Ibritumomab Tiuxetan Ibrutinib Idelalisib Imbruvica (Ibrutinib) Intron A (Recombinant Interferon Alfa- ...
  7. Cancer Drug Information From the National Institutes of Health (National Cancer Institute)  
    ... Hydrochloride) Hyper-CVAD I Ibrance (Palbociclib) Ibritumomab Tiuxetan Ibrutinib ICE Iclusig (Ponatinib Hydrochloride) Idamycin (Idarubicin Hydrochloride) Idarubicin ...
  8. CLL Guide: Information for Patients and Caregivers (Leukemia & Lymphoma Society) - PDF  
    ... in general have milder side effects than chemotherapy. Ibrutinib (Imbruvica ® ) is the first targeted therapy approved for ... Cytoxan®) Doxorubicin (Adriamycin®) Fludarabine (Fludara®) Prednisone Targeted I Ibrutinib (Imbruvica®) Therapy Lenalidomide (Revlimid®) Idelalisib (Zydelig®) Monoclonal I ...
  9. Drugs Approved for Leukemia (National Cancer Institute)  
    ... Cyclophosphamide) Fludara (Fludarabine Phosphate) Fludarabine Phosphate Gazyva (Obinutuzumab) Ibrutinib Idelalisib Imbruvica (Ibrutinib) Leukeran (Chlorambucil) Linfolizin (Chlorambucil) Mechlorethamine ...
  10. ... also be tried. Newer drugs such as ofatumumab, ibrutinib (Imbruvica), and idelalisib (Zydelig) may be other options. ...
previous · 1 · 2 · next
Refine by Type
Refine by Keyword